Digitalis Ventures

Portfolio Companies 2026 for Digitalis Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Digitalis Ventures accounts for 19 tracked companies with verified cap-table data, 19 of which disclose round sizes totalling $2B. The median disclosed raise is $91M, and the largest is Alterome Therapeutics at $231M, ahead of Nuvig Therapeutics ($208M) and Tenvie Therapeutics ($200M).

The names that recur most often on these portfolio cap tables are Digitalis Ventures (19 companies), Sanofi Ventures (3 companies), Abingworth (3 companies), Deerfield Management (3 companies), Atlas Venture (3 companies), OrbiMed (2 companies). By latest disclosed round, the market skews Series A (11), Series B (6), Series C (1), Series D (1).

Best funded Digitalis Ventures companies

  1. Alterome Therapeutics — $231M (latest: Series A)
  2. Nuvig Therapeutics — $208M (latest: Series B)
  3. Tenvie Therapeutics — $200M (latest: Series A)
  4. Protego Biopharma — $181M (latest: Series B)
  5. Ascend Advanced Therapies — $130M (latest: Series A)
  6. Ascend — $130M (latest: Series A)
  7. Matchpoint Therapeutics — $100M (latest: Series A)
  8. Judo Bio — $100M (latest: Series A)
  9. Positive Development — $97M (latest: Series C)
  10. GRO Biosciences — $91M (latest: Series B)
  11. T-Therapeutics — $91M (latest: Series A)
  12. Syntis Bio — $87M (latest: Series A)
  13. Ascend Gene & Cell Therapies — $66M (latest: Series A)
  14. Cara Therapeutics — $56M (latest: Series D)
  15. Switch Therapeutics — $52M (latest: Series A)

Digitalis Ventures — related firms and companies (56)

Digitalis Ventures profile · All research reports